Alkami Technology, Inc.ALKTNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank43
3Y CAGR-32.2%
5Y CAGR-17.5%
Studio
Year-over-Year Change

Year-over-year research & development expense growth

3Y CAGR
-32.2%/yr
Quarterly compound
5Y CAGR
-17.5%/yr
Recent deceleration
Percentile
P43
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 20253.65%
Q3 2025-0.46%
Q2 202512.45%
Q1 20256.06%
Q4 20245.04%
Q3 20240.94%
Q2 20244.77%
Q1 20246.18%
Q4 2023-1.21%
Q3 20234.26%
Q2 20231.54%
Q1 20230.95%
Q4 202211.71%
Q3 20229.80%
Q2 202217.23%
Q1 20229.71%
Q4 20210.20%
Q3 20216.36%
Q2 202110.94%
Q1 20210.65%
Q4 20209.54%
Q3 20201.21%
Q2 20200.94%
Q1 20200.00%